CBPartners
CBPartners is a New York-based, privately held strategy consulting firm founded in 2012 that serves multinational pharmaceutical, biopharmaceutical, and medical device companies, as well as government clients, on strategic issues across the life sciences sector with 101-250 employees.
- Company typePrivate
- Founded2012
- HeadquartersNew York, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What CBPartners does
CBPartners is a private, for-profit strategy consulting firm founded in 2012 and headquartered in New York, United States. The firm provides strategic advisory services to multinational pharmaceutical, biopharmaceutical, and medical device companies, as well as to government clients, focusing on strategic issues in the life sciences sector. With 101-250 employees, CBPartners operates as a specialist boutique in a market typically served by large generalist strategy houses (McKinsey, BCG, Bain) and life sciences-focused consultancies.
The firm generates revenue through professional services engagements — typically multi-month strategy projects covering pricing, market access, launch planning, and commercial strategy for regulated pharma and medtech products. Its narrow industry focus and explicit inclusion of government clients differentiate it from generalist consultancies and from broader life sciences services platforms. The firm has remained privately held since founding, with no public listing, supporting confidentiality on sensitive client engagements and strategic flexibility.
The source data does not disclose named customer logos, disclosed revenue, funding history, leadership team, M&A activity, or product/technology platforms attributable to CBPartners. A substantial block of detailed product, technology, AI, and customer data in the source (referring to TrinityEDGE™, Trinity AI, ForecastEDGE™, 350+ customers, 70% of new drug launches) is explicitly labeled in the source as pertaining to Trinity Life Sciences, not CBPartners, and has therefore not been attributed to CBPartners in this analysis. The most significant data gap is the absence of disclosed financial metrics, named enterprise clients, and any documented growth signals specific to CBPartners.
CBPartners firmographics
Firmographics- Name
- CBPartners
- Legal name
- Trinity
- Website
- https://cbpartners.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- CBPartners is a New York-based, privately held strategy consulting firm founded in 2012 that serves multinational pharmaceutical, biopharmaceutical, and medical device companies, as well as government clients, on strategic issues across the life sciences sector with 101-250 employees.
- Ownership category
- akta.pro rank
Where CBPartners is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
CBPartners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Consulting & Professional Services: Expert consulting services across commercial strategy, evidence strategy (HEOR), value and access, pricing, market research, benchmarking, and analytics for life sciences companies.
- Technology Platform Subscriptions: SaaS platform subscriptions including TrinityEDGE™, InsightsEDGE™, ForecastEDGE™, and Launch Accelerator™ providing ongoing access to data and analytics capabilities.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
CBPartners product offering
Product offeringCore offering
CBPartners is a strategy consulting firm providing strategic advisory services to multinational pharmaceutical, biopharmaceutical, and medical device companies as well as governments. Its core offering combines expert consulting across commercial strategy, evidence/value/access/pricing (including HEOR), market research, benchmarking, and commercial analytics with the TrinityEDGE™ data and analytics platform enhanced by Trinity AI capabilities to support pipeline, launch, and brand optimization stages.
Product overview
Trinity Life Sciences offers a unified platform architecture centered on TrinityEDGE™, a data and analytics platform for life sciences commercialization. The platform is enhanced by AI capabilities through Trinity AI and supplemented by specialized modules including InsightsEDGE™ for integrated insights, ForecastEDGE™ (formerly CloudCast™) for predictive forecasting, MDM for master data management, and Launch Accelerator™ for launch excellence. The product suite also includes Sentiment for sentiment analysis. Services span commercial strategy, evidence/value/access/pricing (including HTA Vision™), market research, benchmarking, and commercial analytics. The overall offering is designed to support pipeline/pre-commercial, launch, and brand optimization stages across biotech, medtech, and pharma industries.
Differentiator
Problem solved
Functional benefit
Brands
- TrinityEDGE™: A data and analytics platform that empowers ongoing decision flow with tools built by experts in life sciences data and analytics.
- Trinity AI
- InsightsEDGE™
- ForecastEDGE™
- MDM
- Launch Accelerator™
- HTA Vision™
Products and services
- TrinityEDGE™
Quantifiable outcome
- Accurately predicting up to 90% of revenue outcomes for drug launches
- +2 more outcomes
Companies that use CBPartners
Customer profileSegments3 records
Ideal customer profiles3 records
CBPartners technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature7 records
CBPartners partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Trinity AlliancesminorThe company maintains an 'Alliances' page (accessible via /company/alliances/) indicating a formal partnerships program, though specific named alliance partners are not listed on the main website page.
Scale indicators4 records
Recent moves3 records
Expansion highlights2 records
CBPartners competitors and assessment
Company assessmentBroad incumbents
- Accenture (Life Sciences practice): Global systems integrator with a large life sciences practice spanning strategy, technology, and operations, increasingly competing on AI-driven commercial transformation. Broad incumbent offering scaled alternatives to specialist firms.
- Veeva Systems: Cloud software provider for life sciences (CRM, data, AI) serving similar pharma commercial and medical affairs users. Adjacent platform peer with stronger software DNA but narrower consulting breadth.
- McKinsey & Company (Healthcare Practice): Top-tier strategy consultancy with a deep pharma/biotech/medtech practice competing for the same enterprise strategy budgets. Broad incumbent not specialized to life sciences but routinely wins the same RFPs.
- IQVIA: Largest life sciences commercial solutions provider globally, offering technology (Orchestrated Analytics), consulting, and data assets across the full pharma value chain. Larger, broader incumbent with overlapping capabilities.
- Syneos Health (now part of Elliott): Clinical and commercial services organization offering commercialization solutions for biopharma. Larger incumbent with broader clinical/contract scope but overlapping commercial deployment.
Direct peers
- ZS Associates: Global management consulting + technology firm focused on life sciences, with a proprietary analytics platform (ZS Discovery, ZAIDYN) and deep pharma/biotech/medtech practice. Most direct peer given overlap in commercialization strategy, analytics, and platform-based subscriptions.
- Beghou Consulting: Pure-play life sciences commercial consulting firm serving pharma and biotech with commercialization, analytics, and market access services. Comparable operating model (consulting-led) and similar client base.
- Indegene: Healthcare/life sciences commercialization company combining consulting, technology, and operations support for global pharma, biotech, and medtech. Closely comparable hybrid model of services plus proprietary platforms.
- Eversana: End-to-end life sciences commercialization services provider spanning market access, patient services, and commercial strategy with proprietary technology. Direct peer in pharma/biotech commercialization with similar buyer personas.
- Putnam Associates: Strategy consulting firm exclusively serving life sciences clients with pricing, market access, and new product planning services. Directly comparable boutique-style consulting positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
CBPartners social profiles
Digital presenceCBPartners financial estimates
Financial estimateRevenue estimate
Valuation estimate
CBPartners leadership team
Management profileNumber of profiles
CBPartners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CBPartners M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CBPartners
What does CBPartners do?
CBPartners is a strategy consulting firm providing strategic advisory services to multinational pharmaceutical, biopharmaceutical, and medical device companies as well as governments. Its core offering combines expert consulting across commercial strategy, evidence/value/access/pricing (including HEOR), market research, benchmarking, and commercial analytics with the TrinityEDGE™ data and analytics platform enhanced by Trinity AI capabilities to support pipeline, launch, and brand optimization stages.
Is CBPartners a public or private company?
CBPartners is a private company. It is classified as unknown and is currently operating.
When was CBPartners founded?
CBPartners was founded in 2012. It employs 101 to 250 people.
Where is CBPartners based?
CBPartners is headquartered in New York, United States, in the North America region.
How does CBPartners make money?
Two revenue lines are on record. Consulting & Professional Services are the primary driver. The others are technology Platform Subscriptions.
Who are CBPartners's main competitors?
Broad incumbents on record are Accenture (Life Sciences practice), Veeva Systems, McKinsey & Company (Healthcare Practice), IQVIA and Syneos Health (now part of Elliott). Direct peers are ZS Associates, Beghou Consulting, Indegene, Eversana and Putnam Associates.
Does CBPartners have an API?
No public API is recorded for CBPartners.